Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

ONMDBullishCorporate Developmentsnews

High materiality8/10

OneMedNet inks 3-year data-partnership with Atropos, boosting ARR and reach

Sep 22, 2026, 8:45 AM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

The multi-year ARR potential and data-access expansion could improve ONMD's revenue visibility and valuation if bookings convert, signaling a step-change in growth trajectory.

AI summary

What happened, with direct paths to the underlying reporting

OneMedNet announces a 3-year subscription partnership with Atropos Health to embed regulatory-grade, multimodal RWD into Atropos’ platform. The collaboration expands ARR and grants Atropos customers access to over 90 million patient journeys and 270 million studies, highlighting strong demand for high-quality data and potential revenue expansion for ONMD.

ONMD partners with Atropos on a 3-year, subscription RWD deal.
Gives Atropos access to 90M patient journeys and 270M studies.
Imaging and multimodal data strengthen evidence beyond claims and EHR datasets.
3-year license creates recurring revenue visibility for ONMD.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.